These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 12205106

  • 1. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
    Yip AG, Brayne C, Easton D, Rubinsztein DC, Medical Research Council Cognitive Function Ageing Study (MRC CFAS).
    J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
    [Abstract] [Full Text] [Related]

  • 2. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD, Fisk JD, Rockwood K.
    Dement Geriatr Cogn Disord; 2003 Sep; 15(1):1-5. PubMed ID: 12457072
    [Abstract] [Full Text] [Related]

  • 3. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C, Winblad B, Fratiglioni L.
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [Abstract] [Full Text] [Related]

  • 4. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M, Figuera-Terré L, Mulet-Pérez B, Arrufat-Cardús MT, Pascual San Emeterio A, Arbeola-Rigau I, Labad-Alquézar A, Vilella-Cuadrada E.
    Rev Neurol; 2006 Sep; 38(9):801-7. PubMed ID: 15152345
    [Abstract] [Full Text] [Related]

  • 5. APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study.
    Keage HA, Matthews FE, Yip A, Gao L, McCracken C, McKeith IG, Rubinsztein DC, Brayne C, MRC Cognitive Function and Ageing Study.
    Age Ageing; 2010 Jan; 39(1):104-11. PubMed ID: 19939808
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY, Sadovnick AD, Feldman H.
    CMAJ; 2004 Oct 12; 171(8):863-7. PubMed ID: 15477624
    [Abstract] [Full Text] [Related]

  • 7. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA.
    Neurology; 1996 Mar 12; 46(3):673-7. PubMed ID: 8618665
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.
    Dement Geriatr Cogn Disord; 2006 Mar 12; 22(1):73-82. PubMed ID: 16699282
    [Abstract] [Full Text] [Related]

  • 9. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.
    Heijmans BT, Slagboom PE, Gussekloo J, Droog S, Lagaay AM, Kluft C, Knook DL, Westendorp RG.
    Am J Med Genet; 2002 Jan 22; 107(3):201-8. PubMed ID: 11807900
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS, Stella F, Radanovic M, Aprahamian I, Bertollucci PH, Forlenza OV.
    Bipolar Disord; 2016 Feb 22; 18(1):71-7. PubMed ID: 26877211
    [Abstract] [Full Text] [Related]

  • 11. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.
    O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM.
    J Am Geriatr Soc; 1998 Dec 22; 46(12):1493-8. PubMed ID: 9848808
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
    Craft S, Teri L, Edland SD, Kukull WA, Schellenberg G, McCormick WC, Bowen JD, Larson EB.
    Neurology; 1998 Jul 22; 51(1):149-53. PubMed ID: 9674794
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O, Alzheimer’s Disease Neuroimaging Initiative.
    JAMA Psychiatry; 2014 Oct 22; 71(10):1183-91. PubMed ID: 25162367
    [Abstract] [Full Text] [Related]

  • 15. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.
    Juva K, Verkkoniemi A, Viramo P, Polvikoski T, Kainulainen K, Kontula K, Sulkava R.
    Neurology; 2000 Jan 25; 54(2):412-5. PubMed ID: 10668704
    [Abstract] [Full Text] [Related]

  • 16. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L.
    Neurology; 2004 Sep 14; 63(5):816-21. PubMed ID: 15365129
    [Abstract] [Full Text] [Related]

  • 17. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S, Dermaut B, Goeman J, Saerens J, Mariën P, Pickut BA, Van den Broeck M, Serneels S, Cruts M, Van Broeckhoven C, De Deyn PP.
    J Neurol Neurosurg Psychiatry; 2003 Aug 14; 74(8):1148-51. PubMed ID: 12876259
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.
    Am J Pathol; 1996 Jun 14; 148(6):2083-95. PubMed ID: 8669492
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.